Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact)

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
出版日: 2021年06月30日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次

当レポートは、2020年以降のサイトメガロウイルステスト市場に対するCOVID-19の影響を詳細に説明しています。サイトメガロウイルス(CMV)は、広く分布している病原体で、世界中で先天性感染症を引き起こしています。 CMVのリスクが高いグループには、免疫不全患者(AIDS患者または臓器移植レシピエント)、未熟児、および新生児などがあります。




  • 主要な業界動向の洞察
  • 2015年~2030年までのセグメント別市場見通し
  • 手技件数、台数、平均販売価格、セグメント別市場価値に関する詳細データ


  • 国別分析
  • SWOT分析
  • 競合動向


  • ヘルスケア制度の国別概要
  • 国別の償還方針
  • 国固有の医療技術に関する規制動向

網羅された企業:DiaSorin Spa、F. Hoffman-LaRoche Ltd、Qiagen NV、Quidel Corp、bioMerieux SA、Bio-Rad Labs Inc.、その他


Product Code: GDME625MM

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Cytomegalovirus(CMV) tests market for the year 2020 and beyond. Cytomegalovirus(CMV) tests are performed for detection of Cytomegalovirus. The CMV infections are mostly prevalent in pregnant women, immunocompromised patients and infants. The tests carried out in laboratories are considered.

The CMV tests include Enzyme Immuno Assay (EIA) Tests, Nucleic Acid Amplification Tests (NAATs) and other CMV test kits.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Cytomegalovirus(CMV) tests and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Cytomegalovirus(CMV) tests market revenue by segment and market outlooks from 2015-2030.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Cytomegalovirus market.
  • Competitive dynamics insights and trends provided for Cytomegalovirus market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Abbott Laboratories, Danaher Corp, bioMerieux SA, MBL International Corporation, Bio-Rad Laboratories, Inc, DiaSorin SpA, Luminex Corp, Qiagen NV, Quidel Corp, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.


Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Cytomegalovirus (CMV) tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Cytomegalovirus(CMV) tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Cytomegalovirus(CMV) tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cytomegalovirus(CMV) tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Cytomegalovirus(CMV) tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.